Compare · IVF vs MDLN
IVF vs MDLN
Side-by-side comparison of INVO Fertility Inc. (IVF) and Medline Inc. (MDLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both IVF and MDLN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $44.15B, about 15548.0x IVF ($2.8M).
- Over the past year, IVF is down 99.1% and MDLN is down 17.9% - MDLN leads by 81.2 points.
- MDLN has been more active in the news (20 items in the past 4 weeks vs 6 for IVF).
- MDLN has more recent analyst coverage (25 ratings vs 0 for IVF).
PerformanceIVF-72.64%MDLN-17.90%
2025-12-16+0.00%2026-06-05
- Company
- INVO Fertility Inc.
- Medline Inc.
- Price
- $1.64-8.15%
- $33.45-0.43%
- Market cap
- $2.8M
- $44.15B
- 1M return
- -17.84%
- -20.36%
- 1Y return
- -99.10%
- -17.90%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- News (4w)
- 6
- 20
- Recent ratings
- 0
- 25
Latest IVF
- INVO Fertility Receives Nasdaq Notification Regarding Late Filing of Quarterly Report on Form 10-Q
- INVO Fertility Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- SEC Form 10-K filed by INVO Fertility Inc.
- INVO Fertility Inc. filed SEC Form 8-K: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review, Financial Statements and Exhibits
- INVO Fertility Announces Fiscal Year 2025 Financial Results
- SEC Form NT 10-Q filed by INVO Fertility Inc.
- INVO Fertility Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits
- INVO Fertility Receives Nasdaq Notification Regarding Late Filing of Annual Report on Form 10-K
- SEC Form SCHEDULE 13G filed by INVO Fertility Inc.
- SEC Form NT 10-K filed by INVO Fertility Inc.
Latest MDLN
- Medline Inc. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Entry into a Material Definitive Agreement
- Large owner Hellman & Friedman Capital Partners X (Parallel), L.P. sold $1,164,385,709 worth of shares (31,868,237 units at $36.54) and disposed of 1,887,801 shares (SEC Form 4)
- Director Healy Patrick J acquired 202,106 shares, increasing direct ownership by 15% to 1,387,921 units (SEC Form 4)
- Large owner Bx Mozart Ml-2 Holdco L.P. sold $1,217,349,994 worth of shares (33,317,824 units at $36.54) and disposed of 438,214 shares (SEC Form 4)
- Large owner Bcp 8 Holdings Mozart Manager L.L.C. sold $1,217,349,994 worth of shares (33,317,824 units at $36.54) and disposed of 438,214 shares (SEC Form 4)
- Medline's Prime Vendor model expands outside the United States
- Medline Inc. announces closing of upsized secondary offering of Class A common stock
- Medline announces participation in upcoming investor conferences
- MediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update
- Large owner Bx Mozart Ml-1 Holdco L.P. converted options into 11,348,698 shares and disposed of 11,348,698 units of Class B Common Stock (SEC Form 4)